View More Recent Stories
-
Increasing unusual call option volume: CME QUBT ASAN SPG RGTI NNOX QBTS BBAI PL HIMX
-
CME Group (CME) Announces $2.1B Annual Variable Dividend and $3B Share Repurchase Program
-
These five capital market stocks are clear winners post election, but is the trend sustainable?
-
CME Group (CME) Reports October 2024 ADV of 24.3 Million Contracts
-
CME Group (CME) Receives Approval to Establish Futures Commission Merchant
-
CME Group (CME) PT Raised to $258 at Oppenheimer
-
CME Group (CME) PT Raised to $181 at BofA Securities
-
CME Group (CME) Tops Q3 EPS by 4c
-
CME Group (CME) call put ratio 15 calls to 1 put with focus on November 210, 230 and 240 calls into quarter results
-
CME Group (CME) call put ratio 4.4 calls to 1 put into quarter results
-
Redburn-Atlantic Downgrades CME Group (CME) to Neutral
-
CME Group (CME) PT Raised to $250 at Citi
-
CME Group (CME) Sets New, All-Time Quarterly and September ADV Records Driven by Growth Across All Asset Classes
-
RBC Capital Starts CME Group (CME) at Sector Perform
-
CME Group (CME) SOFR Futures Reach New Volume and Open Interest Records
-
Citi Opens 90-Day Upside Catalyst Watch on CME Group (CME)
-
Citi Opens 90-Day Upside Catalyst Watch on CME Group (CME)
-
CME Group (CME) Reports Second-Highest Monthly ADV of 31.7 Million Contracts in August
-
BofA Securities Downgrades CME Group (CME) to Underperform
-
CME (CME) And S&P (SPGI) Are Said To Explore Sale Of Post-trade JV Osttra - Bloomberg
-
Piper Sandler Reiterates Overweight Rating on CME Group (CME)
-
CME Group (CME) Reports Record July ADV of 24.8 Million Contracts
-
CME Group (CME) PT Lowered to $225 at Piper Sandler
-
CME Group (CME) Tops Q2 EPS by 2c
-
CME Group (CME) call put ratio 5.3 calls to 1 put with focus on August calls into quarter results
-
CME Group (CME) August 200 straddle priced into quarter results
-
CME Group (CME) PT Lowered to $228 at Oppenheimer
-
CME Group (CME) Appoints Mike Dennis as Global Head of Fixed Income
-
Citi Reiterates Buy Rating on CME Group (CME)
-
CME Group (CME) Reports Record June and Q2 2024 Volumes, Reaching New Highs Across Multiple Asset Classes
-
Barclays Reiterates Equalweight Rating on CME Group (CME)
-
Citi Reiterates Buy Rating on CME Group (CME)
-
JPMorgan Downgrades CME Group (CME) to Underweight
-
Citi Reiterates Buy Rating on CME Group (CME)

